A meta‐analysis involving 33 studies showed that higher sTILs were associated with improved survival in HER2‐positive and TN breast cancer patients,51 while other researchers declared sTILs as a negative prognostic factor in HoR‐positive breast cancer.20, 47. Here, ERBB2 is linked to breast carcinoma.